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 Background: Despite improved antimicrobial therapy and multiple options for drainage of 
infected pleural space, thoracic empyema (TE) continues to cause significant morbidity and 
mortality. The objectives of this study were to assess the causes and treatment outcome of 
patients with thoracic empyema. 
 Methods: Patients aged ≥ 13year with TE who were admitted to Gondar University Teaching 
Hospital, Northwest Ethiopia, from Nov 1999 to Dec 2007 were included. Retrospectively, 
medical records were reviewed and demographic and clinical data were collected. 
Results: Records of 81 patients were analyzed; majority (82%) were below the age 50 year. The 
mean duration of symptoms prior to presentation and hospital stay was 97.4 and 38days, 
respectively. HIV/AIDS was detected in 60%. Causes of empyema were pulmonary tuberculosis 
(56%), pneumonia (36%) and lung abscess (7%). Closed chest tube was inserted in 86% of cases 
and was successful in 93% of them. Case-fatality was 12% and poor outcome occurred in 26%. 
Conclusions: Early identification of TE and aggressive management with antibiotics or 
antituberculosis, drainage with chest tube, and surgical treatment when closed tube drainage 




Thoracic empyema (TE) is characterized by bacterial organisms seen on gram stain or aspiration of 
pus on thoracentesis. Despite improved antimicrobial therapy and multiple options for drainage of the 
infected pleural space, TE continues to cause significant morbidity and mortality. TE is commonly 
caused by pneumonia, lung abscess, tuberculosis, and chest trauma and predisposing factors include 
alcoholism, malignancy, Diabetes mellitus and HIV infection1-11 . The mortality rate of TE in different 
studies ranges from 4.7% to 24 %2-5,8-11. Antibiotic therapy and drainage of the pleural space remain 
the first line of therapy for TE11. Early adequate operative drainage in patients with TE results in low 
morbidity, shorter stays in hospital, and good long term outcome8.  In our set up the available methods 
for drainage are therapeutic aspiration and intercostal drainage tube connected to water seal. There 
was one study done in Ethiopia which studied retrospectively patients with TE who were treated in 
Tikur Anbessa Hospital where chest surgery service is available3. To the best of our knowledge there 
is no study done in Gondar University Teaching Hospital (GUTH) in patients with TE. This study was 
designed to assess the clinical presentation, cause, predisposing factors, treatment and out come of 
patients with TE who presented to GUTH, Northwest Ethiopia. 
  
Patients and Methods 
 
In this hospital-based retrospective study patient aged 13 years and above who were admitted to 
Gondar University Teaching Hospital with the diagnosis of thoracic empyema from Novenber 1999 to 
December 2007 were included. The diagnosis of thoracic empyema was based on the finding of gross 
purulent exudate or pleural fluid culture or Gram stain showing organisms. The study was started after 
getting ethical clearance from the Research and Publication Office of the University of Gondar. 
Confidentiality was assured by assigning each patient record a unique number.  
 
Medical records of eligible patients were manually searched and datasheet was prepared to collect the 
following data: age, gender, address, presenting symptoms and signs, duration of illness, predisposing 
factors, investigations, chest x-ray, treatment, complications, duration of hospital stay and outcome at 
hospital discharge and cause of death. Successful chest tube drainage was defined as clinical and 
 




radiological improvement. Poor outcome included both deteriorated and dead patients. Tuberculose 
empyema was diagnosed based on clinical presentation, suggestive investigations, chest x-ray and 
favorable response to antituberculosis drugs. The data were analyzed using SPSS version 13.0 for 




Data from 81 patients with empyema thoracis were analyzed. There were 47 males and 34 females. 
The ages ranged from 16 to 90 with a mean of 36.6 years and a peak was in the 21-30 age group. The 
presenting symptoms are shown in Table 1. Right-side chest findings slightly outnumbered left-side 
chest findings (Table 3). 
 
More than one type of chest x-ray findings were detected in some patients. Pleural fluid was frank pus 
in 74 (91.4%) of patients and the mean pleural fluid cell count was 16,038 cells/mm3 (range 340 -
110,650). Gram staining of the fluid was revealing in 29(36%) of cases: Gram positive (n=21), Gram 
negative (n=2), and both types of organisms (n=6). Acid-fast staining of the empyema showed 
mycobacterial species in 2 patients. Culture of the empyema grew bacteria in 12(15%) of cases: S. 
aureus (n=5), streptococcus species (n=3), proteus species (n=2), pseudomonas species (n=1) and 
Klebsella Ozenae (n=1). 
 
Pathological examination was done in 9 patients and revealed inflammatory empyema. Sputum acid-
fast staining and fine-needle aspiration of lymph node showed evidence of tuberculosis in one patient 
each. 
 
Table 1. Presenting Symptoms. 
 
Symptoms Number of Patients % 
Cough 79 97.5 
Fever 76 93.8 
Sputum production 67 82.7 
Weight loss 64 79.0 
Chest pain 63 77.8 
Shortness of breath 61 75.3 
Night sweating 58 71.6 
Chills 27 33.3 
Haemoptysis 22 27.2 
spontaneous drainage of empyema 5 6.2 
 
 
Table 2. Physical Signs Identified. 
 
Physical sign Number of Patients % 
Signs of pleural effusion 59 72.8 
Signs of hydropneumothorax 22 27.2 
Crepitations 22 27.2 
Signs of consolidation 21 25.9 
Tracheal/mediastinal deviation 19 23.5 
Lymphadenopathy 12 14.8 
Change in mentation 4 4.9 
Cyanosis 4 4.9 
Pleural friction rub 2 2.5 
Wheezes 2 2.5 
 
 




Table 3. Chest X-ray Findings in 78 Patients. 
  
Chest x-ray Findings Suggestive of:  Number of Patients % 
Fluid 44 56.4 
Hydropneumothorax 35 44.9 
Consolidation 10 12.8 
Parenchymal  infiltrates 7 9.0 
Collapsed lung 6 7.7 
Fibrotic changes 3 3.8 
Hilar mass 2 2.6 
Cavity 2 2.6 
Milliary pattern 1 1.3 
Pleural thickening 1 1.3 
 
Peripheral blood examination showed leukocytosis in 7.4%, in leucopenia 26.5%, anaemia in 65.6% 
and high erythrocyte sedimentation rate (ESR) in 96.9% of cases with mean value of 94 mm in the 
first hour. Serology test for HIV was done in 53(65.4%) and it was positive in 32(60.4%) cases. Chest 
ultrasound showed loculated empyema in 7 patints and subphrenic abscess in 1 case.  
 
Causes of empyema were pulmonary tuberculosis in 45 (55.6%), pneumonia in=29 (35.8%), lung 
abscess in 6 (7.4%) and subphrenic abscess in 1 (1.2%) of the cases. Of the 32 patients with HIV 




Anti-tuberculosis and antibiotics were respectively given to 45 (55.6%) and 77 (95.1%) of the 
patients. Seventy (90.9%) cases required 2 or more types of antibiotics and the duration of treatment 
ranged from 1 to 49 days with a mean of 25days. Chest tube was inserted in 70 (86.4%) and it was 
successful in 65 (92.9%) of the cases. The mean interval in days between admission to hospital and 
chest tube insertion was 2.1 days with a range of 0 to 13 days. The mean duration of stay of chest tube 
before removal was 14 days (range3 to 66). Chest tube reinsertion was required in 9(13%) patients 
and the indications for reinsertion were recollection of empyema in 7 and pneumothorax  in 2 patients. 




Outcome at hospital discharge was cure or improved in 60 (74.1%), deterioration without death in 11 
(13.6%) and death in 10  (12.3%). The cause of death was septic shock in 7 and respiratory failure in 
3 of the cases. Among the deceased 7 (70%) were males. HIV test was done in 6 of the patients who 
died; 3 had tested positive. Poor outcome tht is the sum of those who died and those who deteriorated 
was 21(26%). In patients with poor outcome HIV test was done in 13 patients and it was positive in 7 
of them. 
  
The following sequelae were observed at discharge: collapsed lung (n=9), empyema necessitance 
(n=8), pneumothorax (n=5), fibrothorax (n=4), and bronchopleural fistula (n=4). After hospital 




The objectives of our study were to analyze the clinical presentation, causes, treatment and outcome 
of patients with thoracic empyema admitted to Gondar University Teaching Hospital. The types of 
treatment that were given to these patients were antibiotics, antituberculosis, aspiration(s), and 
intercostal drainage tube connected to water seal. Surgical treatment (decortication etc) was not 
available. Most other thoracic empyema studies showed male preponderance.1-4 Similarly in our series 
 




58% were males. Majority of our patients (81.5%) were below the age 50 which is consistent with 
other studies done in Africa .2-4 This mainly reflects the Ethiopian demographics that projected that 
95.6% of the population would be ≤ 59 year old in 2005.12 
 
In this study there was marked delay at presentation of patients to our hospital. The mean duration of 
symptoms prior to presentation was 3.2 months which is long compared to other studies done in 
Zambia4 and Pakistan5 which was 1.4 and 1.5 months , respectively. The mean hospital stay was 38 
days which is consistent with other studies 3,11which was 43.2 and 37days, respectively. A shorter 
mean hospital stay (19.8days) was observed in another study .1 Previous study has suggested that 
delay to drainage of an infected pleural space is associated with increased morbidity and hospital 
stay.8 
 
The commonest cause of thoracic empyema in our series was pulmonary tuberculosis (55.6%) which 
is similar to other studies done in Africa which ranges from 48.7% to 63.2%.2-4 In a study done in 
India, pulmonary tuberculosis caused thoracic empyema in 21% of cases.6 Th  second commonest 
cause identified in our study was pneumonia(35.8%) which is the commonest etiology of thoracic 
empyema in other studies ranging from 46.7 % to 94.9% .1,5,8,10,11 The commonest serous associated 
disease identified in our study was HIV/AIDS (60.4%) which is similar to a study done in Zambia 
(66.7%).4 Associated malignancy which occurred in 23% of patients in one study 11 was not identified 
in our cases which is similar to a study done in Tanzania.2 Late referral for surgical management of 
empyema thoracis had a significantly greater incidence of anemia .8 The high incidence of anemia in 
our patients (65.6%) might be explained by the marked delay at presentation and the high incidence of 
associated HIV/AIDS. 
 
Thoracostomy tube drainage success rate from previous studies ranged from 46.6% to 86%.3,5,10,11 In 
our series the success rate was 86.4%. Previous studies showed that the mortality of thoracic 
empyema ranges from 4.7% to 24% .2-5,8-11 Mortality rate may be as high as 10% in healthy patients 
and 50% in elderly and debilitated patients .5 The hospital mortality rate in our study was 12.3%; it 
may have been lower due to younger age group. In a prospective study of patients with pleural 
infection, early and aggressive treatment with chest tube drainage and antibiotics was associated with 
good outcome (mortality 4.7%) and emphasizes the need for rapid and effective intervention in this 
disease.9The high percentage of patients with poor outcome (26%) probably indicates the marked 
delay at presentation, the unavailability of surgical treatment when closed tube drainage fails and the 




Most of our patients were young males and presented with cough, fever, expectoration and weight 
loss. There was marked delay at presentation and the commonest cause was pulmonary tuberculosis 
followed by pneumonia. Underlying HIV/AIDS was found in 60% of cases.  
 
High mortality and poor outcome was noted in our series 12.3% and 26%, respectively. Early 
identification of thoracic empyema and aggressive management with antibiotics or antituberculosis, 
drainage with chest tube, surgical treatment when tube drainage fails is recommended to improve 
mortality and morbidity.  
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